Category: Johnson & Johnson
Here's a look at some of the top Wall Street stories for medical device companies this week: Year in review: 2014 was the year of the medtech IPO; Symmetry Medical closes surgical spinout, OEM sale; Inogen affirms 2014 outlook, predicts 2015 growth of up to 25%
, Johnson & Johnson
, Nevro Corp.
, Ocular Therapeutix Inc.
, Symmetry Medical Inc.
, Symmetry Surgical
, Tecomet Inc.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtech M&A explodes in 2014; Synergetics pays $14m for Sterimedix; Report: Lawyer says Guidant didn't breach deal with J&J
Guidant was within its rights to give due diligence materials to Abbott, even though it had an acquisition deal going with Johnson & Johnson, a former Guidant lawyer reportedly testifies.
The number of initial public offerings for medical device companies jumped fourfold in 2014, according to a MassDevice.com analysis.
Click to enlarge
It was, as predicted, the year of the IPO for medical device companies, with 25 filing initial public offerings during 2014, according to a MassDevice.com analysis.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA gives the green light to Stimwave's mini spinal cord stimulator; HeartFlow wins FDA OK for non-invasive FFR system; FDA warns AngioDynamics subsidiary Navilyst on hairs in PICC packaging; Philips defib updates spur ConMed electrode recall; FDA approves J&J spinal device for rare pediatric syndrome
Here's a look at some of the top legal news stories for medical device companies this week: Supremes decline review of Stryker loss to Hill-Rom; Appeals court vacates $177m Covidien award in spat with J&J; BMC Medical claims win in patent spat with ResMed; Ex-ArthroCare CFO wants a new trial too
Johnson & Johnson's DePuy Synthes Spine unit wins an FDA nod for a titanium rod device for the treatment of a rare congenital condition known as thoracic insufficiency syndrome.